The occurrence and progression of MG involves a complex immune regulatory network, including multiple immune cell interactions, cytokines, and different complement activation pathways, and CD4+ T lymphocytes play an important role in the synthesis of MG pathogenic antibodies (16). Here, CD4 is linked to myasthenia gravis.